Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

PurposeA subset of patients treated for Lyme disease report persistent or recurrent symptoms of unknown etiology named post-treatment Lyme disease syndrome (PTLDS). This study aims to describe a cohort of participants with early, untreated Lyme disease, and characterize post-treatment symptomatology and functional impact of PTLDS over time.MethodsSixty-three participants with erythema migrans and systemic symptoms were enrolled in a prospective cohort study. Participants underwent physical exams and clinical assessments, and completed the SF-36 (daily life functioning) and the Beck Depression Inventory, Second Edition (BDI-II) (depression), at each of five visits over a period of 6 months.ResultsSigns of Lyme disease disappeared post-treatment; however, new-onset patient-reported symptoms increased or plateaued over time. At 6 months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties. However, less than 10% reported greater than “minimal” depression across the entire period. Those with PTLDS (36%) did not differ significantly from those without with respect to demographics, pre-treatment SF-36, and BDI-II scores. Statistically significant differences were found over time on the Role Physical, Vitality, Social Functioning, Role Emotional, and Mental Health subscales (with a trend toward significance for the remaining three subscales of Physical Functioning, Bodily Pain, and General Health) of the SF-36 between those with an eventual PTLDS diagnosis and those without when measured at 6 months.ConclusionsUnlike clinical signs of Lyme disease, new-onset symptoms are reported by a subset of participants without evidence of depressive symptomatology. Patients who developed PTLDS had significantly lower life functioning compared to those without PTLDS. We propose future avenues for researching infection-triggered symptoms resulting from multiple mechanisms.

[1]  A. Steere,et al.  The clinical evolution of Lyme arthritis. , 1987, Annals of internal medicine.

[2]  F. Strle,et al.  Subjective symptoms after treatment of early Lyme disease. , 2010, The American journal of medicine.

[3]  J. Godwin,et al.  Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. , 2005, International journal of epidemiology.

[4]  D. Cooper,et al.  Improving the Yield of Blood Cultures from Patients with Early Lyme Disease , 2011, Journal of Clinical Microbiology.

[5]  C. Chiros,et al.  Factor structure and psychometric characteristics of the beck depression inventory-II , 1997 .

[6]  J. D. Young.  Underreporting of Lyme disease. , 1998, The New England journal of medicine.

[7]  E. Shapiro.  Long-term outcomes of persons with Lyme disease. , 2000, Vector borne and zoonotic diseases.

[8]  G. Wormser,et al.  Anti-Borrelia burgdorferi Antibody Profile in Post-Lyme Disease Syndrome , 2011, Clinical and Vaccine Immunology.

[9]  C. Phillips,et al.  Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease , 1999, Annals of Internal Medicine.

[10]  J. Halperin,et al.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  I. Hickie,et al.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.

[12]  K. Kroenke,et al.  Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. , 1989, The American journal of medicine.

[13]  M. Meeus,et al.  Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome , 2006, Clinical Rheumatology.

[14]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[15]  A. Steere,et al.  Memory impairment and depression in patients with Lyme encephalopathy , 1992, Neurology.

[16]  David Schlossberg,et al.  Clinical Infectious Disease: Clinical Syndromes – Respiratory Tract , 2008 .

[17]  Tapabrata Maiti,et al.  Analysis of Longitudinal Data (2nd ed.) (Book) , 2004 .

[18]  J. Meek,et al.  Underreporting of Lyme disease by Connecticut physicians, 1992. , 1996, Journal of public health management and practice : JPHMP.

[19]  J. Halperin,et al.  Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134)) , 2007 .

[20]  G. Wormser.  Clinical practice. Early Lyme disease. , 2006, The New England journal of medicine.

[21]  B. Luft,et al.  Azithromycin Compared with Amoxicillin in the Treatment of Erythema Migrans: A Double-Blind, Randomized, Controlled Trial , 1996, Annals of Internal Medicine.

[22]  B. Kollen,et al.  A Double-blind Randomized Controlled Trial , 2011 .

[23]  Dean A. Pollina,et al.  Psychological states and neuropsychological performances in chronic Lyme disease. , 1999, Applied neuropsychology.

[24]  A. Steere,et al.  Lyme Disease Associated with Fibromyalgia , 1992, Annals of Internal Medicine.

[25]  R. Dornbush,et al.  Duration of Antibiotic Therapy for Early Lyme Disease , 2003, Annals of Internal Medicine.

[26]  S. Buyske,et al.  Role of psychiatric comorbidity in chronic Lyme disease. , 2008, Arthritis and rheumatism.

[27]  L. Jason,et al.  Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities in a Community-Based Sample of Persons With Chronic Fatigue Syndrome-Like Symptoms , 2000, Psychosomatic medicine.

[28]  A. Steere,et al.  Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. , 2003, The American journal of medicine.

[29]  R. Nadelman,et al.  Long-term follow-up of patients with culture-confirmed Lyme disease. , 2003, The American journal of medicine.

[30]  M. Peterson,et al.  Lyme disease: an infectious and postinfectious syndrome. , 1994, The Journal of rheumatology.

[31]  R. Nadelman,et al.  The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. , 1996, The American journal of medicine.

[32]  Commentary: 'What's in a name? That which we call a rose by any other name would smell as sweet.' Shakespeare W. Romeo and Juliet, II, ii(47-48). , 2005, International journal of epidemiology.

[33]  K. Roelofs,et al.  Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. , 2007, Clinical psychology review.

[34]  B. Luft,et al.  Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi , 2009, Antimicrobial Agents and Chemotherapy.

[35]  K. Hegmann,et al.  The Incidence of Fibromyalgia and Its Associated Comorbidities: A Population-Based Retrospective Cohort Study Based on International Classification of Diseases, 9th Revision Codes , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[36]  U. Wurster,et al.  Chronic neurologic manifestations of Lyme disease. , 1991, The New England journal of medicine.

[37]  R A Steer,et al.  Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. , 1999, Journal of clinical psychology.

[38]  A. Steere,et al.  Elucidation of Lyme arthritis , 2004, Nature Reviews Immunology.

[39]  A. Steere.  Medical progress. Lyme disease , 1989 .

[40]  A. Steere,et al.  Treatment of the early manifestations of Lyme disease. , 1983, Annals of internal medicine.

[41]  P. Diggle,et al.  Analysis of Longitudinal Data , 2003 .

[42]  R. Dornbush,et al.  Clinical and neurocognitive features of the post Lyme syndrome. , 1996, The Journal of rheumatology.

[43]  A. Steere,et al.  Evaluation of study patients with Lyme disease, 10-20-year follow-up. , 2001, The Journal of infectious diseases.

[44]  C H Schmid,et al.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. , 2001, The New England journal of medicine.

[45]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.